Pfizer, CDM clean up at Doctors' Choice

Professional ads for Pfizer's Chantix and Organon's NuvaRing were the year's top-rated as judged by physicians in the Association of Medical Media's fifth annual Doctors' Choice Awards.

The two-page Chantix ad, executed by Euro RSCG Life LM&P, was the top-scoring professional ad in the general practice category, while the one-page NuvaRing ad, by CommonHealth's Adient, took top honors in the specialty category.

The survey, which drew responses from 6,040 physicians, included 332 professional ads in 11 therapeutic categories among the 200 most widely advertised products for 2006.

Pfizer was the year's big winner with a total of five awards— for top scoring one- and two-page ads as well as the highest-ranked ads within the cardiovascular and anti-infective categories. Genentech/OSI, Merck and Organon each took home two awards.

On the agency side, Cline Davis & Mann was tops with four awards—three for Pfizer and one for Novo Nordisk's Novolog Flexpen—while AbelsonTaylor, Euro RSCG Life LM&P and CommonHealth's Adient each won two, respectively.

The awards were presented at a September 20 luncheon held at the New York Palace hotel in New York City.

You must be a registered member of MMM to post a comment.

Next Article in Features

Content marketing is not advertising in the old sense. In its use of social media, content marketing challenges consumers while relying on their input. It is proactive and responsive to their concerns, needs and energy. Content marketing has become the new voice of marketing. Learn what you need to know and how pharma marketers can adapt to this innovative venture into social media by clicking here for access.

Email Newsletters